Joseph Daval News Today

Panelists at the leading health economics and outcomes conference discuss whether the FDA's process for allowing outside experts to weigh in on drug approvals needs changes.

Polling consistently shows many adults aren’t aware of the Inflation Reduction Act provisions intended to drive down health costs.

From today through the end of September, the FDA has scheduled seven meetings of its expert panels, none of which will be in person.

This past week in healthcare investigations